Aimz Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Aimz Investment Advisors, LLC

  • $289 Million
  • Q3 2024

A detailed history of Aimz Investment Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Aimz Investment Advisors, LLC holds 53,249 shares of BMY stock, worth $2.99 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
53,249
Previous 53,419 0.32%
Holding current value
$2.99 Million
Previous $2.22 Million 24.21%
% of portfolio
0.95%
Previous 0.8%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$39.66 - $51.75 $6,742 - $8,797
-170 Reduced 0.32%
53,249 $2.76 Million
Q2 2024

Aug 07, 2024
BUY
$40.25 - $52.99 $32,159 - $42,339
799 Added 1.52%
53,419 $2.22 Million
Q1 2024

May 10, 2024
BUY
$47.98 - $54.4 $5,037 - $5,712
105 Added 0.2%
52,620 $2.85 Million
Q4 2023

Jan 26, 2024
BUY
$48.48 - $57.85 $97,153 - $115,931
2,004 Added 3.97%
52,515 $2.69 Million
Q3 2023

Nov 13, 2023
SELL
$57.89 - $64.73 $15,861 - $17,736
-274 Reduced 0.54%
50,511 $2.93 Million
Q2 2023

Aug 08, 2023
SELL
$63.71 - $70.74 $6,179 - $6,861
-97 Reduced 0.19%
50,785 $3.25 Million
Q1 2023

May 15, 2023
SELL
$65.71 - $74.53 $58,941 - $66,853
-897 Reduced 1.73%
50,882 $3.53 Million
Q4 2022

Feb 10, 2023
SELL
$68.48 - $81.09 $35,404 - $41,923
-517 Reduced 0.99%
51,779 $3.73 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $3 - $2,074
27 Added 0.05%
52,296 $3.72 Million
Q2 2022

Aug 02, 2022
BUY
$72.62 - $79.98 $217 - $239
3 Added 0.01%
52,269 $4.03 Million
Q1 2022

May 06, 2022
SELL
$61.48 - $73.72 $106,852 - $128,125
-1,738 Reduced 3.22%
52,266 $3.82 Million
Q4 2021

Feb 09, 2022
BUY
$53.63 - $62.52 $99,376 - $115,849
1,853 Added 3.55%
54,004 $3.37 Million
Q3 2021

Nov 12, 2021
BUY
$59.17 - $69.31 $608,740 - $713,061
10,288 Added 24.58%
52,151 $3.09 Million
Q2 2021

Aug 05, 2021
BUY
$61.91 - $67.42 $185 - $202
3 Added 0.01%
41,863 $2.8 Million
Q1 2021

Apr 28, 2021
SELL
$59.34 - $66.74 $15,013 - $16,885
-253 Reduced 0.6%
41,860 $2.64 Million
Q4 2020

Feb 08, 2021
SELL
$57.74 - $65.43 $8,372 - $9,487
-145 Reduced 0.34%
42,113 $2.61 Million
Q3 2020

Nov 13, 2020
SELL
$57.43 - $63.64 $34,113 - $37,802
-594 Reduced 1.39%
42,258 $2.55 Million
Q2 2020

Aug 07, 2020
BUY
$54.82 - $64.09 $45,500 - $53,194
830 Added 1.98%
42,852 $2.52 Million
Q1 2020

May 12, 2020
BUY
$46.4 - $67.43 $232 - $337
5 Added 0.01%
42,022 $2.34 Million
Q4 2019

Feb 13, 2020
BUY
$49.21 - $64.19 $1.83 Million - $2.38 Million
37,155 Added 764.19%
42,017 $2.7 Million
Q3 2019

Nov 13, 2019
SELL
$42.77 - $50.71 $9,623 - $11,409
-225 Reduced 4.42%
4,862 $247,000
Q2 2017

Aug 15, 2017
BUY
N/A
5,087
5,087 $283,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aimz Investment Advisors, LLC Portfolio

Follow Aimz Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aimz Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aimz Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email